Cspc Zhongqi Pharmaceutical Technology Co., Ltd.

This study tests a new drug (glumetinib) combined with chemotherapy for people with advanced stomach cancer or related tumors that have a specific gene change (MET overexpression or amplification). The goal is to see if the combination is safe and can shrink tumors. About 350 adu…

This study tests whether adding a new form of sirolimus to a standard hormone-blocking drug (octreotide) can better control advanced neuroendocrine tumors of the stomach, intestines, or pancreas. About 298 adults with tumors that cannot be removed by surgery will receive the comb…

This study is for people with advanced solid tumors that cannot be removed by surgery or have spread. It tests a combination of sirolimus (a targeted drug) with different antibody-drug conjugates (ADCs) to see if it is safe and works. About 444 adults aged 18 to 75 will take part…

This study tests an investigational drug called CM326 in people with moderate to severe chronic obstructive pulmonary disease (COPD). The goal is to see if it can reduce the number of serious flare-ups and improve lung function. About 318 adults aged 40 to 85 with a history of at…

This early-stage study is testing a new drug called SYH2085 in healthy Chinese adults to see if it is safe and how the body handles it. About 74 participants will receive either the drug or a placebo. The goal is to check for side effects and measure drug levels in the blood, not…